-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Immunocore Holdings, Maintains $71 Price Target

Benzinga·04/10/2025 11:11:32
Listen to the news
Needham analyst Gil Blum reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $71 price target.